AMW Revenue

Pharmaceutical Manufacturing • Holzkirchen, Bavaria, Germany • 51-100 Employees

AMW revenue & valuation

Annual revenue	$5,500,000
Revenue per employee	$65,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$17,600,000
Total funding	$30,200,000

Key Contacts at AMW

Philipp Karbach

Ceo

Benjamin Wittmann

Deputy Head Of Production Ldh

Company overview

Headquarters	11 Birkerfeld, Warngau, Bavaria 83627, DE
Phone number	+49802447099929
Websites	amw-pharmaceuticals.com a-m-w.eu
NAICS	3254
Keywords	Pharmaceuticals, Research And Development, Formulation Development, Implants, Value-Added Medicines, Entire Pharmaceutical Value-Chain, Goserelin, Leuprorelin, Life-Cycle Solutions, Symptomatic Therapy Of Hormone-Dependent Tumors, Cdmo+, Controlled-Release Drug Delivery Systems, Cost-Effective Therapies
Founded	2008
Employees	51-100
Socials

AMW Email Formats

AMW uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@amw-pharmaceuticals.com), used 88.7% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@amw-pharmaceuticals.com	88.7%
{first initial}.{last name}	j.doe@amw-pharmaceuticals.com	11.3%

About AMW

Controlled drug delivery for superior treatment. For patients, worldwide. AMW’s mission as a specialty pharmaceutical company is to provide patients and our partners with value-added medicines for improved adherence and cost-effective therapies. With our focus on biodegradable controlled-release drug delivery systems suited for almost any indication, we build on our growing development pipeline. Based on our unparalleled expertise in formulation development, we collaborate with pharma and biotech partners worldwide to develop and manufacture high-quality products and life-cycle solutions. We cover the entire value chain, from (co-)development to manufacturing and international commercialization via direct sales and out-licensing. Our experienced and agile team of drug delivery experts dedicated to improving patients’ lives, are crucial to our success. Our unique expertise in formulation development and technology application allows us to design, manufacture and commercialize high-quality biodegradable controlled-release drug delivery systems. AMW has two approved medicinal products, implants releasing goserelin and leuprorelin, which are distributed worldwide via direct sales and out-licensing.

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Manager

Entry

Vice President

Employees by Department

AMW has 37 employees across 11 departments.

Departments

Number of employees

Funding Data

Explore AMW's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2018-02-04	1	$30,200,000

Funding Insights

$30,200,000

Total funding amount

$30,200,000

Most recent funding amount

Number of funding rounds

Frequently asked questions

AMW is located in Holzkirchen, Bavaria, DE.

You can reach AMW at +49802447099929.

AMW generates an estimated annual revenue of $5,500,000. This revenue figure reflects the company's market position and business performance in its industry.

AMW has an estimated valuation of $17,600,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

AMW was founded in 2008, making it 18 years old. The company has established itself as a significant player in its industry over this time.

AMW has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.

AMW has raised a total of $30,200,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at AMW

Philipp Karbach

Ceo

Benjamin Wittmann

Deputy Head Of Production Ldh

4.8

40,000 users